Candriam SCA’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-900,104
| Closed | -$11.9M | – | 706 |
|
|
2024
Q4 | $11.9M | Buy |
900,104
+66,888
| +8% | +$881K | 0.07% | 241 |
|
|
2024
Q3 | $9.34M | Hold |
833,216
| – | – | 0.05% | 279 |
|
|
2024
Q2 | $8.96M | Buy |
833,216
+285,216
| +52% | +$3.07M | 0.05% | 270 |
|
|
2024
Q1 | $8.17M | Buy |
548,000
+95,000
| +21% | +$1.42M | 0.05% | 277 |
|
|
2023
Q4 | $8.2M | Buy |
453,000
+138,000
| +44% | +$2.5M | 0.06% | 279 |
|
|
2023
Q3 | $5.46M | Buy |
315,000
+50,000
| +19% | +$867K | 0.04% | 299 |
|
|
2023
Q2 | $4.8M | Buy |
265,000
+25,000
| +10% | +$453K | 0.03% | 343 |
|
|
2023
Q1 | $5.88M | Buy |
+240,000
| New | +$5.88M | 0.04% | 332 |
|